Invention Grant
US09320774B2 Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer
有权
降低前列腺癌细胞放射线抗性和/或治疗前列腺癌的方法
- Patent Title: Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer
- Patent Title (中): 降低前列腺癌细胞放射线抗性和/或治疗前列腺癌的方法
-
Application No.: US14262512Application Date: 2014-04-25
-
Publication No.: US09320774B2Publication Date: 2016-04-26
- Inventor: Chih-Ho Lai , Yu-Hsin Lin , Cheng-Kuo Lai , Chia-Shuo Chang
- Applicant: CHINA MEDICAL UNIVERSITY
- Applicant Address: TW Taichung
- Assignee: CHINA MEDICAL UNIVERSITY
- Current Assignee: CHINA MEDICAL UNIVERSITY
- Current Assignee Address: TW Taichung
- Agency: Andrews Kurth LLP
- Agent Ping Wang
- Priority: TW103102246A 20140122
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K38/16 ; A61K38/36 ; A61P35/00 ; B82Y5/00 ; A61K9/16 ; A61N5/10
Abstract:
A method for reducing the radio-resistance of prostate cancer cells in a subject in need thereof, comprising administering to the subject an effective amount of an active component, wherein the active component is a nanoparticle of a carrier encapsulated with cytolethal distending toxin subunit B (CdtB).
Public/Granted literature
- US20150202254A1 METHOD FOR REDUCING RADIO-RESISTANCE OF PROSTATE CANCER CELLS AND/OR TREATING PROSTATE CANCER Public/Granted day:2015-07-23
Information query
